Response to Comments: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers

This document (A59838) is an administrative 'Response to Comments' regarding MolDX LCD DL39636 for gene expression profile tests in castration-resistant and metastatic prostate cancer; it does not contain substantive coverage criteria. For specific indications, limitations, documentation requirements, and frequency limits consult LCD DL39636 (effective 09/22/2024).

"This document is a 'Response to Comments' notice for MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers and does not itself define cove..."

Sign up to see full coverage criteria, indications, and limitations.